Institutional Knowledge Map (KMap)
Map
Services
How To Use
About
Toggle theme
Loading...
Menu
Jazmin Dagnino
Clinical Research Coordinator III
College of Medicine - Tucson
Map Page
Research Area
viral persistence,
immune dysregulation,
post-acute sequelae,
clinical trials,
autoimmune diseases,
medication efficacy,
safety assessment,
immunology,
interventions,
sars-cov-2 infection
Grants
(4)
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants with Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-1)
Active
·
2024
·
$0 / $277.3K
·
External
clinical trials,
autoimmune diseases,
medication efficacy,
safety assessment,
immunology
A Phase 1 Study to Evaluate the Efficacy and Safety Of AB-101, an Allogeneic Cord Blood Derived NK-Cell Therapy in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III
Active
·
2024
·
$0 / $141.8K
·
External
cell therapy,
immunotherapy,
cancer treatment,
clinical trial
RECOVER-VITAL: A Platform Protocol for Evaluation of Interventions for Viral Persistence, Viral Reactivation, and Immune Dysregulation in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Active
·
2023
·
$0 / $1.8M
·
External
viral persistence,
immune dysregulation,
interventions evaluation,
sars-cov-2,
post-acute sequelae
RECOVER-VITAL: A Platform Protocol for Evaluation of Interventions for Viral Persistence, Viral Reactivation, and Immune Dysregulation in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Active
·
2023
·
$0 / $5.5K
·
External
viral persistence,
interventions,
immune dysregulation,
post-acute sequelae,
sars-cov-2 infection
Collaborations
(8)
Sairam Parthasarathy
Mutual work: 2 Proposals﹒1 Grant
Collaboration Details
C. Kent Kwoh
Mutual work: 2 Grants﹒2 Proposals
Collaboration Details
Franz Rischard
Mutual work: 1 Grant﹒2 Proposals
Collaboration Details
Kirsten Anderson
Mutual work: 2 Proposals﹒2 Grants
Collaboration Details
Gustavo Cornejo
Mutual work: 2 Grants﹒2 Proposals
Collaboration Details
Page 1 of 2
Previous page
Next page
7+ Collaborators
$0 / $2.2M Funding
